Patients suffering from neurodegenerative disorders such as Alzheimer's disease, Parkinson's disease or multiple sclerosis present with devastating cognitive and function disabilities. Through the development of novel biomarkers and imaging tools a large European consortium is aiming to improve the diagnosis and treatment outcome for these patients.
Further information: cordis.europa.eu